APA (7th ed.) Citation

C.K. Vidyaraj, A. Chitra, S. Smita, M. Muthuraj, S. Govindarajan, B. Usharani, & S. Anbazhagi. (2019). Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes. Springer.

Chicago Style (17th ed.) Citation

C.K. Vidyaraj, A. Chitra, S. Smita, M. Muthuraj, S. Govindarajan, B. Usharani, and S. Anbazhagi. Prevalence of Rifampicin-resistant Mycobacterium Tuberculosis Among Human-immunodeficiency-virus-seropositive Patients and Their Treatment Outcomes. Springer, 2019.

MLA (9th ed.) Citation

C.K. Vidyaraj, et al. Prevalence of Rifampicin-resistant Mycobacterium Tuberculosis Among Human-immunodeficiency-virus-seropositive Patients and Their Treatment Outcomes. Springer, 2019.